Anika Therapeutics reported $-984000 in EBIT for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbott ABT:US $ 2331M 232M
Acceleron Pharma XLRN:US $ -63603000 6.01M
Acorda Therapeutics ACOR:US $ -26657000 6.16M
Adamas Pharmaceuticals ADMS:US -14977000 6.21M
Agenus AGEN:US $ -41371000 16.23M
Agios Pharmaceuticals AGIO:US $ -91217000 1.22M
Anika Therapeutics ANIK:US $ -984000 5.08M
Arrowhead Research ARWR:US $ -28232000 4.18M
Chemocentryx CCXI:US $ -29327000 254K
Dicerna Pharmaceuticals DRNA:US $ -29107000 2.54M
Enanta Pharmaceuticals ENTA:US $ -29700000 17.4M
Halozyme Therapeutics HALO:US $ 77.62M 37.32M
Immunogen IMGN:US $ 36.48M 53.21M
Insmed INSM:US $ -83833000 10.7M
Integra Lifesciences IART:US $ 57.9M 18.74M
Johnson & Johnson JNJ:US $ 7580.4M 3038.4M
Karyopharm Therapeutics KPTI:US $ -52373000 15.31M
Ligand Pharmaceuticals LGND:US $ 5.14M 11.04M
Macrogenics MGNX:US $ -51293000 49.12M
Merit Medical Systems MMSI:US $ 24.8M 113K
Rigel Pharmaceuticals RIGL:US $ 41.76M 60.58M
Sangamo Biosciences SGMO:US $ -46302000 2.87M
Stryker SYK:US $ 590M 511M
Surmodics SRDX:US $ 9.48M 9.39M
Veracyte VCYT:US $ -8072000 4.01M
Xencor XNCR:US $ -15672000 1.97M